SAN DIEGO—ResMed's revenue for the June 2009 quarter was $252 million, a 7 percent increase over the same quarter last year. Income from operations was $57.9 million and net income was $45.4 million, a yearly increase of 57 percent and 53 percent, respectively.
For the year ended June 30, revenue was $920.7 million, a 10 percent increase over revenue in the previous year. Income from operations and net income were $190.3 million and $146.4 million, increases of 33 percent over those figures from last year.
“The fact that the market for sleep-disordered breathing therapy remains highly underpenetrated and the drive to increase the awareness of SDB and improve patient compliance seem to have shielded us from the economic factors affecting many other companies,” Kieran T. Gallahue, ResMed president and CEO, said in a statement.
“Continuing to raise awareness about the relationship between sleep-disordered breathing/obstructive sleep apnea and co-morbidities such as cardiac disease, diabetes, hypertension and obesity as well as our efforts in the occupational health and safety space, with a particular focus on the transport industry, bode well for future continued growth.”
